mask share gain
strong result share gain continu report robust
result underli ebit yoy cs estim
non-gaap ep yoy higher cs estim
takeaway includ strong mask growth us row
us devic growth continu uptak airsens
gross margin prior year benefit
manufacturing/procur effici product mix chang higher
contribut saa continu oper leverag sg cc
vs revenu cc lower guidanc sg a/sal
remind previou guidanc
gain share mask devic view continu
benefit broadest product portfolio launch four new
mask past month well excess
peer breadth product portfolio continu rise re-suppli
enabl consist strong growth mask sale forecast
growth us row continu best-
place devic due airview data platform forecast us
devic sale continu grow market growth
support grow trend toward in-hom sleep test increas
rate new patient set-up stabl price environ us
next month new rate begin
maintain outperform rate increas target price
follow ep upgrad upgrad
trade cs revis ep premium
market line two-year averag increas invest
data platform remain upbeat abil use data improv
qualiti care patient home set increas
penetr rate within sleep copd market note current
forecast includ addit upsid potenti long-term
synergi recent saa acquisit
catalysts/risk new product launch outcom round
valuat metric
chang previou ep
price month
total return forecast perspect
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
price book
return equiti
return asset
return invest cap
net debt ebitda
capital-expenditure sale
capital-expenditure depr
price oct rate outperform target price analyst gretel janu
profit tax
profit tax
unusu item tax
chang work capit
cash non-cash item
movement cash/equival
 asx close
spot exchang rate
net interest
net profit tax
sale divis
gross margin consist
revenu yoy cs forecast
manag note continu take share healthcar provid
physician choos script continu uptak
revenu yoy cs forecast cycl strong comp
mask continu good traction strong launch new
mask continu re-suppli growth
saa benefit acquisit expect double-digit growth
saa revenu yoy
saa revenu aid full quarter contribut matrixcar healthcar
first acquisit underli basi saa busi grew high single-digit
manag expect saa achiev double-digit sale growth medium
still cycl upgrad chang franc japan reimburs
month ago manag note underli demand remain healthi particular
strong growth uk switzerland nordic
continu gain traction mask categori get benefit recent
gross margin improv higher proport saa revenu
gross profit cs forecast gross margin
vs prior quarter matrixcar accret
gross margin remaind benefit due manufactur effici
favour product mix partial off-set typic asp declin
sg exclud acquisit sg would cc
sg percentag revenu improv
ahead cs estim
 vs pcp ex acquisit revenu
cs forecast
earn dividend
non-gaap ep ahead cse
quarterli dividend line forecast
incorpor number chang forecast follow result
share gain increas estim row devic assum greater stabil
revenu chang saa double-digit growth forecast
gross margin minor increas gross margin due stronger result
sg assum abl achiev greater oper leverag vs
tax rate decreas tax rate previous line guidanc
currenc updat cs in-hous currenc forecast relev fx exposur
aggreg increas non-gaap ep estim
averag thereaft dcf-deriv target price increas
maintain outperform rate
figur long-term multipl
figur trade premium market
pe multipl rel xji ex-financi
chart bloomberg credit suiss estim
net interest
net profit tax
figur us group revenu
revenu composit segment
revenu segment us mn
figur us driven revenu
revenu segment us mn
figur us mask growth remain strong
revenu growth segment cc
figur gross margin yoy
figur yoy
cost revenu
chart compani data credit suiss estim
figur us growth pick
figur devic account sale
mix sale
figur forecast shift mask
chart compani data credit suiss estim
new total return forecast perspect chart help visual credit suiss consensu view compani return within
context forecast risk histor trade pattern
volatil calcul annualis standard deviat weekli total return seri past month illustr variabl
stock return word risk way think one would rather take forecast return stock volatil
stock volatil shade area show one standard deviat rang base past month volatil statist
term make number brave assumpt probabl share price end insid rang month
hi-lo maximum minimum daili close price past week often handi know price momentum especi
stock trade close high low stock trade close peak momentum stock
consensu consensu suppli thomson reuter survey sell side research analyst collect dozen data
point ep dp sale target price roe mean averag target return shade area around mean
repres rang estim lowest highest estim aid visualis number import factor rang
analyst estim credit suiss estim stock sit rel consensu share price rel consensu
mean consensu rang target
return calcul capit gain plu forecast dividend yield net next month cs tgt use credit suiss
target price credit suiss forecast forward dividend gross frank consensu mean rang use
consensu target price consensu dividend forecast month forward
compani mention price
